Treatment approaches in myelofibrosis with myeloid metaplasia: The old and the new
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 40, 18-21
- https://doi.org/10.1053/shem.2003.50029
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasiaBlood, 2003
- Polycythemia Vera: A Comprehensive Review and Clinical RecommendationsMayo Clinic Proceedings, 2003
- Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in miceBlood, 2002
- Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietinAmerican Journal of Hematology, 2002
- Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and managementBlood Reviews, 2001
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- The role of transforming growth factor‐β in PEG‐rHuMGDF‐induced reversible myelofibrosis in ratsBritish Journal of Haematology, 1997
- Identification of ‘short‐lived’ and ‘long‐lived’ patients at presentation of idiopathic myelofibrosisBritish Journal of Haematology, 1997
- Induction and maintenance alpha‐interferon therapy in myelofibrosis with myeloid metaplasiaEuropean Journal of Haematology, 1990